Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome.
Journal
Nature cell biology
ISSN: 1476-4679
Titre abrégé: Nat Cell Biol
Pays: England
ID NLM: 100890575
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
07
12
2020
accepted:
24
01
2022
entrez:
16
3
2022
pubmed:
17
3
2022
medline:
5
4
2022
Statut:
ppublish
Résumé
Transfer RNA-derived fragments (tRFs) are emerging small noncoding RNAs that, although commonly altered in cancer, have poorly defined roles in tumorigenesis
Identifiants
pubmed: 35292784
doi: 10.1038/s41556-022-00852-9
pii: 10.1038/s41556-022-00852-9
pmc: PMC8924001
doi:
Substances chimiques
PAIP1 protein, human
0
Peptide Initiation Factors
0
RNA-Binding Proteins
0
Pseudouridine
1445-07-4
RNA, Transfer
9014-25-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
299-306Informations de copyright
© 2022. The Author(s).
Références
Rosace, D., Lopez, J. & Blanco, S. Emerging roles of novel small non-coding regulatory RNAs in immunity and cancer. RNA Biol. 17, 1196–1213 (2020).
Guzzi, N. et al. Pseudouridylation of tRNA-derived fragments steers translational control in stem cells. Cell 173, 1204–1216 (2018).
doi: 10.1016/j.cell.2018.03.008
pubmed: 29628141
Craig, A. W. B., Haghighat, A., Yu, A. T. K. & Sonenberg, N. Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation. Nature 392, 520–523 (1998).
doi: 10.1038/33198
pubmed: 9548260
Pelletier, J., Graff, J., Ruggero, D. & Sonenberg, N. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development. Cancer Res. 75, 250–263 (2015).
doi: 10.1158/0008-5472.CAN-14-2789
pubmed: 25593033
pmcid: 4299928
Ge, J. & Yu, Y. T. RNA pseudouridylation: new insights into an old modification. Trends Biochem. Sci. 38, 210–218 (2013).
doi: 10.1016/j.tibs.2013.01.002
pubmed: 23391857
pmcid: 3608706
Behm-Ansmant, I. et al. The Saccharomyces cerevisiae U2 snRNA:pseudouridine-synthase Pus7p is a novel multisite-multisubstrate RNA:Psi-synthase also acting on tRNAs. RNA 9, 1371–1382 (2003).
doi: 10.1261/rna.5520403
pubmed: 14561887
pmcid: 1287059
Schwartz, S. et al. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 159, 148–162 (2014).
doi: 10.1016/j.cell.2014.08.028
pubmed: 25219674
pmcid: 4180118
Kahvejian, A., Svitkin, Y. V., Sukarieh, R., M’Boutchou, M. N. & Sonenberg, N. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Gene Dev. 19, 104–113 (2005).
doi: 10.1101/gad.1262905
pubmed: 15630022
pmcid: 540229
Chalmers, M. J., Busby, S. A., Pascal, B. D., West, G. M. & Griffin, P. R. Differential hydrogen/deuterium exchange mass spectrometry analysis of protein–ligand interactions. Expert Rev. Proteomics 8, 43–59 (2011).
doi: 10.1586/epr.10.109
pubmed: 21329427
pmcid: 3113475
Roy, G. et al. Paip1 interacts with poly(A) binding protein through two independent binding motifs. Mol. Cell. Biol. 22, 3769–3782 (2002).
doi: 10.1128/MCB.22.11.3769-3782.2002
pubmed: 11997512
pmcid: 133836
Khaleghpour, K. et al. Dual interactions of the translational repressor Paip2 with poly(A) binding protein. Mol. Cell. Biol. 21, 5200–5213 (2001).
doi: 10.1128/MCB.21.15.5200-5213.2001
pubmed: 11438674
pmcid: 87244
Khaleghpour, K. et al. Translational repression by a novel partner of human poly(A) binding protein, Paip2. Mol. Cell 7, 205–216 (2001).
doi: 10.1016/S1097-2765(01)00168-X
pubmed: 11172725
Tcherkezian, J. et al. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′ TOP mRNA translation. Gene Dev. 28, 357–371 (2014).
doi: 10.1101/gad.231407.113
pubmed: 24532714
pmcid: 3937514
Schuster, S. L. & Hsieh, A. C. The untranslated regions of mRNAs in cancer. Trends Cancer 5, 245–262 (2019).
doi: 10.1016/j.trecan.2019.02.011
pubmed: 30961831
pmcid: 6465068
Ingolia, N. T., Brar, G. A., Rouskin, S., McGeachy, A. M. & Weissman, J. S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat. Protoc. 7, 1534–1550 (2012).
doi: 10.1038/nprot.2012.086
pubmed: 22836135
pmcid: 3535016
Meyuhas, O. & Kahan, T. The race to decipher the top secrets of TOP mRNAs. Biochim. Biophys. Acta 1849, 801–811 (2015).
doi: 10.1016/j.bbagrm.2014.08.015
pubmed: 25234618
Truitt, M. L. & Ruggero, D. New frontiers in translational control of the cancer genome. Nat. Rev. Cancer 16, 288–304 (2016).
doi: 10.1038/nrc.2016.27
pubmed: 27112207
pmcid: 5491099
Gandin, V. et al. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 455, 684–U681 (2008).
doi: 10.1038/nature07267
pubmed: 18784653
pmcid: 2753212
Kirn-Safran, C. B. et al. Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29. Dev. Dyn. 236, 447–460 (2007).
doi: 10.1002/dvdy.21046
pubmed: 17195189
Valli, R. et al. Different loss of material in recurrent chromosome 20 interstitial deletions in Shwachman–Diamond syndrome and in myeloid neoplasms. Mol. Cytogenet. 6, 56 (2013).
Qi, Y. K. et al. Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome. Sci. Rep. 7, 2323 (2017).
Wu, L. Y. et al. Over-expression of RPL23 in myelodysplastic syndromes is associated with apoptosis resistance of CD34
doi: 10.1007/s00277-012-1486-2
pubmed: 22580751
Fonseca, B. D., Lahr, R. M., Damgaard, C. K., Alain, T. & Berman, A. J. LARP1 on TOP of ribosome production. Wiley Interdiscip. Rev. RNA 9, e1480 (2018).
Philippe, L., van den Elzen, A. M. G., Watson, M. J. & Thoreen, C. C. Global analysis of LARP1 translation targets reveals tunable and dynamic features of 5′ TOP motifs. Proc. Natl Acad. Sci. USA 117, 5319–5328 (2020).
doi: 10.1073/pnas.1912864117
pubmed: 32094190
pmcid: 7071917
Cockman, E., Anderson, P. & Ivanov, P. TOP mRNPs: molecular mechanisms and principles of regulation. Biomolecules 10, 969 (2020).
Jerez, A. et al. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood 119, 6109–6117 (2012).
doi: 10.1182/blood-2011-12-397620
pubmed: 22553315
pmcid: 3383019
Sperling, A. S., Gibson, C. J. & Ebert, B. L. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat. Rev. Cancer 17, 5–19 (2017).
doi: 10.1038/nrc.2016.112
pubmed: 27834397
Malcovati, L. et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 122, 2943–2964 (2013).
doi: 10.1182/blood-2013-03-492884
pubmed: 23980065
pmcid: 3811170
Shiozawa, Y. et al. Gene expression and risk of leukemic transformation in myelodysplasia. Blood 130, 2642–2653 (2017).
doi: 10.1182/blood-2017-05-783050
pubmed: 29097382
Guo, Y. et al. Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes. BMC Genomics 16, 727 (2015).
doi: 10.1186/s12864-015-1929-y
pubmed: 26400237
pmcid: 4581457
Stevens, B. M. et al. Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes. Nat. Commun. 9, 3694 (2018).
doi: 10.1038/s41467-018-05984-x
pubmed: 30209285
pmcid: 6135858
Tohyama, K. et al. A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages. Br. J. Haematol. 91, 795–799 (1995).
doi: 10.1111/j.1365-2141.1995.tb05391.x
pubmed: 8547120
Signer, R. A., Magee, J. A., Salic, A. & Morrison, S. J. Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature 509, 49–54 (2014).
doi: 10.1038/nature13035
pubmed: 24670665
pmcid: 4015626
Dimitriou, M. et al. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality. Oncotarget 7, 72685–72698 (2016).
doi: 10.18632/oncotarget.12234
pubmed: 27683035
pmcid: 5341937
Chen, J. et al. Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level. Nat. Med. 25, 103–110 (2019).
doi: 10.1038/s41591-018-0267-4
pubmed: 30510255
Theocharides, A. P. A., Rongvaux, A., Fritsch, K., Flavell, R. A. & Manz, M. G. Humanized hemato-lymphoid system mice. Haematologica 101, 5–19 (2016).
doi: 10.3324/haematol.2014.115212
pubmed: 26721800
pmcid: 4697887
Goncalves, K. A. et al. Angiogenin promotes hematopoietic regeneration by dichotomously regulating quiescence of stem and progenitor cells. Cell 166, 894–906 (2016).
doi: 10.1016/j.cell.2016.06.042
pubmed: 27518564
pmcid: 4988404
Lagadinou, E. D. et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12, 329–341 (2013).
pubmed: 23333149
pmcid: 3595363
Skrtic, M. et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell 20, 674–688 (2011).
doi: 10.1016/j.ccr.2011.10.015
pubmed: 22094260
pmcid: 3221282
Majetl, R. et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc. Natl Acad. Sci. USA 106, 3396–3401 (2009).
doi: 10.1073/pnas.0900089106
Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391–2405 (2016).
doi: 10.1182/blood-2016-03-643544
pubmed: 27069254
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
doi: 10.1186/gb-2009-10-3-r25
pubmed: 19261174
pmcid: 2690996
Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
doi: 10.1093/bioinformatics/btp120
pubmed: 19289445
pmcid: 2672628
Dunn, J. G. & Weissman, J. S. Plastid: nucleotide-resolution analysis of next-generation sequencing and genomics data. BMC Genomics 17, 958 (2016).
Lauria, F. et al. riboWaltz: optimization of ribosome P-site positioning in ribosome profiling data. PLoS Comput. Biol. 14, e1006169 (2018).
doi: 10.1371/journal.pcbi.1006169
pubmed: 30102689
pmcid: 6112680
Malcovati, L. et al. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 126, 233–241 (2015).
doi: 10.1182/blood-2015-03-633537
pubmed: 25957392
pmcid: 4528082